Antiphospholipid syndrome in Latin American patients: Clinical and immunologic characteristics and comparison with European patients

Lupus

Volumn 16, Issue 5, 2007, Pages 366-373

  Garcia Carrasco M ^a,b   Galarza, C ^c   Gomez Ponce M ^a   Cervera, R ^d   Rojas Rodriguez J ^b   Espinosa, G ^d   Bucciarelli, S ^d   Gomez Puerta J A ^d   Bove A ^d   Escarcega R O ^a   Font, J ^d  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b BENEMÉRITA UNIVERSIDAD AUTÓNOMA DE PUEBLA   (Mexico)

^c Hospital Monte Sinai   (Ecuador)

^d HOSPITAL CLÍNIC   (Spain)

Author keywords

Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Ethnicity; Lupus anticoagulant

Indexed keywords

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; BRAIN ISCHEMIA; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE COURSE; ECUADOR; ENVIRONMENTAL FACTOR; ETHNIC GROUP; EUROPE; FEMALE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOLOGY; LIVEDO RETICULARIS; MAJOR CLINICAL STUDY; MALE; MEXICO; MIGRAINE; PREVALENCE; PRIORITY JOURNAL; SEROLOGY; SKIN NECROSIS; SKIN ULCER; SOCIOECONOMICS; SOUTH AND CENTRAL AMERICA; THROMBOCYTOPENIA; TRANSIENT GLOBAL AMNESIA; TRANSITIONAL BLINDNESS;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; CHILD; COHORT STUDIES; ECUADOR; EUROPE; FEMALE; HUMANS; MALE; MEXICO; MIDDLE AGED;

EID: 34447529158     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203307077108     Document Type: Article

References (29)

1. Asherson RA, Cervera R, Piette JC, Shoenfeld Y. Milestones in the antiphospholipid syndrome. In Asherson RA, Cervera R, Piette JC, Shoenfeld Y eds. The antiphospholipid syndrome II-Autoimmune Thrombosis. Elsevier, 2002: 3-9.
2. Font J, López-Soto A, Cervera R et al. The 'primary' antiphospholipid syndrome: Antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 1991; 9: 69-75.
3. Asherson RA, Cervera R, Piette JC et al. Catastrophic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 2001; 80: 355-377.
4. Alarcón-Segovia D, Delezé M, Oria CV et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989; 68: 353-365.
5. Muñoz-Rodríguez FJ, Font J, Cervera R et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 1999; 29: 182-190.
6. Vianna JL, Khamashta MA, Ordi-Ros J et al. Comparison of the primary and secondary antiphospholipid syndrome. A European multicenter study of 131 patients. Am J Med 1994; 96: 3-9.
7. Asherson RA, Khamashta MA, Ordi-Ros J et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989; 68: 366-374.
8. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 2002; 46: 1019-1027.
9. Wilson WA. Ethnicity and APS. J Autoimmun 2000; 15: 153-155.
10. Uthman I, Khamashta M. Ethnic and geographical variation in antiphospholipid (Hughes) syndrome. Ann Rheum Dis 2005; 64: 1671-1676.
11. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-1311.
12. Tan EM, Cohen AS, Fries J et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
13. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-324.
14. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-347.
15. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581-590.
16. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-347.
17. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Arthritis Rheum 1990; 33: 1065-1144.
18. Asherson RA, Cervera R, Piette JC, Shoenfeld Y eds. The antiphospholipid syndrome II-Autoimmune Thrombosis. Elsevier, 2002.
19. Ad hoc committee on classification of headaches. Classification and diagnostic criteria for headaches disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8(Suppl 7): 8-96.
20. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-222.
21. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190.
22. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332: 993-997.
23. Derksen RHWM, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004; 50: 1028-1039.
24. Wilson WA, Gharavi AE. Genetic risk factors for aPL syndrome. Lupus 1996; 5: 398-403.
25. Sanchez ML, Katsumata K, Atsumi T et al. Association of HLA-DM polymorphism with the production of antiphospholipid antibodies. Ann Rheum Dis 2004; 63: 1645-1648.
26. Yasuda S, Atsumi T, Matsuura E et al. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine 247 beta2-glycoprotein I variant. Arthritis Rheum 2005; 52: 212-218.
27. Caliz R, Atsumi T, Kondeatis E et al. HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. Rheumatology 2001; 40: 31-36.
28. Reveille JD, Moulds JM, Ahn Ch. Systemic lupus erythematosus in three ethnic groups. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. Arthritis Rheum 1998; 41: 1161-1172.
29. Alarcon GS, Rodriguez JL, Benavides G. Systemic lupus erythematosus in three ethnic groups. Acculturation, health-related attitudes and behaviors, and disease activity in Hispanic patients from the LUMINA cohort. Arthritis Care Research 1999; 12: 267-274.